(Z)-4,6-DIHYDROXY-2-(4-HYDROXY-3-METHOXYBENZYLIDENE)BENZOFURAN-3-(2H)-ONE


Source	Gaulton A, Kale N, van Westen GJ, Bellis LJ, Bento AP, Davies M, Hersey A, Papadatos G, Forster M, Wege P, Overington JP. A large-scale crop protection bioassay data set. Sci Data. 2015 Jul 7;2:150032. Read more ...


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Structure


InChI Key	RPIRXLWYWRSESA-RZNTYIFUSA-N
Smiles	COc1cc(\C=C\2/Oc3cc(O)cc(O)c3C2=O)ccc1O
InChI	InChI=1S/C16H12O6/c1-21-12-4-8(2-3-10(12)18)5-14-16(20)15-11(19)6-9(17)7-13(15)22-14/h2-7,17-19H,1H3/b14-5-

Physicochemical Descriptors

Property Name	Value
Molecular Formula	C16H12O6
Molecular Weight	300.26
AlogP	2.39
Hydrogen Bond Acceptor	6.0
Hydrogen Bond Donor	3.0
Number of Rotational Bond	2.0
Polar Surface Area	96.22
Molecular species	NEUTRAL
Aromatic Rings	2.0
Heavy Atoms	22.0

Assay Description	Organism	Bioactivity
Herbicidal activity against Paraixeris denticulata assessed as germination rate at 1000 ug/ml measured on fourth day post dose (Rvb = 100%)	Paraixeris denticulata	100.0 %
Herbicidal activity against Paraixeris denticulata assessed as germination rate at 1000 ug/ml measured on third day post dose (Rvb = 97.4 +/- 0.6%)	Paraixeris denticulata	94.9 %
Herbicidal activity against Paraixeris denticulata assessed as germination rate at 1000 ug/ml measured on second day post dose (Rvb = 76.7 +/- 0.3%)	Paraixeris denticulata	82.4 %
Herbicidal activity against Paraixeris denticulata assessed as germination rate at 1000 ug/ml measured on first day post dose (Rvb = 30.8 +/- 1.2%)	Paraixeris denticulata	14.3 %
Herbicidal activity against Digitaria sanguinalis (hairy crabgrass) assessed as germination rate at 1000 ug/ml measured on third day post dose (Rvb = 100%)	Digitaria sanguinalis	100.0 %
Herbicidal activity against Digitaria sanguinalis (hairy crabgrass) assessed as germination rate at 1000 ug/ml measured on second day post dose (Rvb = 100%)	Digitaria sanguinalis	35.1 %
Herbicidal activity against Digitaria sanguinalis (hairy crabgrass) assessed as germination rate at 1000 ug/ml measured on first day post dose (Rvb = 0%)	Digitaria sanguinalis	0.0 %
Herbicidal activity against Echinochloa crus-galli (barnyard grass) plants assessed as germination rate at 1000 ug/ml measured on second day post dose (Rvb = 100%)	Echinochloa crus-galli	100.0 %
Herbicidal activity against Echinochloa crus-galli (barnyard grass) plants assessed as germination rate at 1000 ug/ml measured on first day post dose (Rvb = 49.1 +/- 1.6%)	Echinochloa crus-galli	16.9 %
Herbicidal activity against Echinochloa crus-galli (barnyard grass) plants assessed as inhibition of seedling growth at 1000 ug/ml after 65 hr by barnyard cup test	Echinochloa crus-galli	23.3 %
Herbicidal activity against Echinochloa crus-galli (barnyard grass) plants assessed as inhibition of seedling growth at 100 ug/ml after 65 hr by barnyard cup test	Echinochloa crus-galli	9.5 %
Herbicidal activity against Brassica rapa subsp. oleifera assessed as inhibition of root growth at 1000 ug/ml after 65 hr by rape cup test	Brassica rapa subsp. oleifera	98.4 %
Herbicidal activity against Brassica rapa subsp. oleifera assessed as inhibition of root growth at 100 ug/ml after 65 hr by rape cup test	Brassica rapa subsp. oleifera	63.3 %
Herbicidal activity against Brassica rapa subsp. oleifera assessed as inhibition of root growth at 10 ug/ml after 65 hr by rape cup test	Brassica rapa subsp. oleifera	None

Cross References

Resources	Reference
ChEMBL	CHEMBL199712
PubChem	6476404
SureChEMBL	SCHEMBL5707762

CONTENTS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).